Stock Market & Financial Investment News

News Breaks October 12, 2012 15:25 EDT CYCC, CYCC, CYCC Cyclacel Pharmaceuticals to hold a conference call Management discusses updated Phase 2 survival data of Cyclacel's Sapacitabine for MDS which was presented at the recent 8th Annual Hematologic Malignancies Conference in a conference call to be held on October 15 at 3:30 pm. Webcast Link News For CYCC From The Last 14 Days Check below for free stories on CYCC the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 16, 2013 10:00 EDT CYCC Cyclacel Pharmaceuticals falls 10.1% Cyclacel Pharmaceuticals is down 10.1%, or 35c, to $3.12 09:03 EDT CYCC Cyclacel Pharmaceuticals 6.667M share Spot Secondary priced at $3.00 Subscribe for More Information May 15, 2013 16:02 EDT CYCC Cyclacel Pharmaceuticals files to sell common stock, no amount given Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.